Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 15 | 2022 | 298 | 2.430 |
Why?
|
| Analgesics, Opioid | 10 | 2022 | 498 | 1.470 |
Why?
|
| Chronic Pain | 4 | 2020 | 110 | 1.380 |
Why?
|
| Education, Medical, Continuing | 3 | 2018 | 136 | 1.230 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2021 | 504 | 1.010 |
Why?
|
| Guideline Adherence | 2 | 2018 | 287 | 1.000 |
Why?
|
| Physicians | 2 | 2018 | 324 | 0.910 |
Why?
|
| Pain Management | 5 | 2017 | 186 | 0.880 |
Why?
|
| Pain | 5 | 2014 | 472 | 0.880 |
Why?
|
| Buprenorphine | 6 | 2021 | 67 | 0.790 |
Why?
|
| Prescription Drug Monitoring Programs | 2 | 2021 | 34 | 0.720 |
Why?
|
| Prescription Drugs | 3 | 2017 | 71 | 0.670 |
Why?
|
| Internship and Residency | 2 | 2022 | 596 | 0.510 |
Why?
|
| Program Development | 1 | 2017 | 240 | 0.510 |
Why?
|
| Pancreatitis, Chronic | 2 | 2014 | 168 | 0.500 |
Why?
|
| Health Policy | 1 | 2017 | 221 | 0.500 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 214 | 0.490 |
Why?
|
| Prescription Drug Misuse | 1 | 2013 | 35 | 0.430 |
Why?
|
| Psychiatry | 2 | 2022 | 112 | 0.360 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2010 | 11 | 0.360 |
Why?
|
| Disulfiram | 1 | 2010 | 22 | 0.350 |
Why?
|
| Bradycardia | 1 | 2010 | 45 | 0.350 |
Why?
|
| Thiazoles | 1 | 2010 | 95 | 0.340 |
Why?
|
| Quinolones | 1 | 2010 | 60 | 0.340 |
Why?
|
| Piperazines | 1 | 2010 | 206 | 0.320 |
Why?
|
| Antipsychotic Agents | 1 | 2010 | 247 | 0.300 |
Why?
|
| Substance-Related Disorders | 3 | 2022 | 1242 | 0.290 |
Why?
|
| Humans | 31 | 2022 | 68618 | 0.290 |
Why?
|
| Psychomotor Disorders | 1 | 2006 | 4 | 0.280 |
Why?
|
| Dysarthria | 1 | 2006 | 9 | 0.280 |
Why?
|
| Cerebellar Ataxia | 1 | 2006 | 8 | 0.280 |
Why?
|
| Sodium Oxybate | 1 | 2006 | 13 | 0.280 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 86 | 0.260 |
Why?
|
| Male | 18 | 2022 | 37321 | 0.260 |
Why?
|
| Female | 17 | 2022 | 38074 | 0.250 |
Why?
|
| Cocaine-Related Disorders | 1 | 2010 | 504 | 0.240 |
Why?
|
| Adult | 15 | 2022 | 21403 | 0.240 |
Why?
|
| Suicide | 2 | 2017 | 116 | 0.240 |
Why?
|
| Opiate Substitution Treatment | 3 | 2021 | 57 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2022 | 2800 | 0.200 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2021 | 7 | 0.200 |
Why?
|
| Hyponatremia | 1 | 2021 | 20 | 0.200 |
Why?
|
| Pain Measurement | 5 | 2014 | 328 | 0.200 |
Why?
|
| Alcoholism | 1 | 2010 | 1109 | 0.190 |
Why?
|
| Hyperalgesia | 2 | 2011 | 18 | 0.190 |
Why?
|
| Pain Perception | 2 | 2011 | 22 | 0.190 |
Why?
|
| Quality of Life | 2 | 2020 | 1515 | 0.170 |
Why?
|
| South Carolina | 4 | 2020 | 2752 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2019 | 186 | 0.150 |
Why?
|
| Oxycodone | 1 | 2017 | 10 | 0.140 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2011 | 413 | 0.140 |
Why?
|
| Middle Aged | 9 | 2020 | 21147 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2017 | 107 | 0.140 |
Why?
|
| Drug Overdose | 1 | 2017 | 67 | 0.140 |
Why?
|
| Health Personnel | 1 | 2019 | 286 | 0.140 |
Why?
|
| Health Services | 2 | 2013 | 87 | 0.130 |
Why?
|
| Adolescent | 3 | 2020 | 8912 | 0.120 |
Why?
|
| Withholding Treatment | 1 | 2014 | 35 | 0.120 |
Why?
|
| Young Adult | 4 | 2020 | 5717 | 0.120 |
Why?
|
| Patient Preference | 1 | 2015 | 57 | 0.120 |
Why?
|
| Phototherapy | 1 | 2014 | 28 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 581 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 81 | 0.120 |
Why?
|
| Heart-Assist Devices | 1 | 2017 | 221 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 286 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2017 | 7029 | 0.110 |
Why?
|
| Perception | 1 | 2014 | 189 | 0.110 |
Why?
|
| Affect | 1 | 2014 | 218 | 0.110 |
Why?
|
| Emotions | 2 | 2014 | 244 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2017 | 621 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 2013 | 113 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1553 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2012 | 60 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 235 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2013 | 188 | 0.100 |
Why?
|
| Analgesics | 1 | 2012 | 118 | 0.100 |
Why?
|
| Aged | 4 | 2020 | 14862 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2017 | 2007 | 0.090 |
Why?
|
| Depression | 2 | 2014 | 943 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 317 | 0.090 |
Why?
|
| Delusions | 1 | 2010 | 20 | 0.090 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2010 | 24 | 0.090 |
Why?
|
| Lithium Carbonate | 1 | 2010 | 31 | 0.090 |
Why?
|
| Analgesia | 1 | 2010 | 58 | 0.090 |
Why?
|
| Antimanic Agents | 1 | 2010 | 21 | 0.090 |
Why?
|
| Aripiprazole | 1 | 2010 | 43 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 2279 | 0.090 |
Why?
|
| Functional Laterality | 1 | 2010 | 240 | 0.090 |
Why?
|
| Alcohol Deterrents | 1 | 2010 | 86 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2010 | 173 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2012 | 400 | 0.080 |
Why?
|
| Pain Clinics | 1 | 2009 | 8 | 0.080 |
Why?
|
| Motivation | 1 | 2013 | 561 | 0.080 |
Why?
|
| Psychotic Disorders | 1 | 2010 | 157 | 0.080 |
Why?
|
| United States | 2 | 2020 | 7367 | 0.080 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 147 | 0.080 |
Why?
|
| Heart Failure | 1 | 2017 | 1180 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2021 | 383 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2014 | 824 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2010 | 307 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2010 | 601 | 0.070 |
Why?
|
| Weight Lifting | 1 | 2006 | 15 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 659 | 0.070 |
Why?
|
| Atrophy | 1 | 2006 | 112 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2009 | 294 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2006 | 107 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2011 | 659 | 0.060 |
Why?
|
| Hospitalization | 1 | 2011 | 978 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 640 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2021 | 703 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 711 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2014 | 1342 | 0.060 |
Why?
|
| Risk Factors | 1 | 2014 | 5731 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 415 | 0.060 |
Why?
|
| Controlled Substances | 1 | 2021 | 5 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2022 | 69 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2021 | 83 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 127 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 211 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 4655 | 0.050 |
Why?
|
| Social Stigma | 1 | 2020 | 53 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2010 | 1506 | 0.040 |
Why?
|
| Length of Stay | 2 | 2013 | 780 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 184 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2022 | 374 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 319 | 0.040 |
Why?
|
| Rural Population | 1 | 2019 | 398 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2009 | 1330 | 0.030 |
Why?
|
| Galvanic Skin Response | 1 | 2014 | 67 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 2013 | 28 | 0.030 |
Why?
|
| Saliva | 1 | 2014 | 142 | 0.030 |
Why?
|
| Inpatients | 1 | 2014 | 208 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 291 | 0.030 |
Why?
|
| Craving | 1 | 2014 | 200 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.030 |
Why?
|
| Heart Rate | 1 | 2014 | 568 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2011 | 50 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 281 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 2334 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 319 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 267 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2011 | 158 | 0.020 |
Why?
|
| Cues | 1 | 2014 | 654 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2011 | 532 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2011 | 170 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 706 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1451 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 948 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 3259 | 0.010 |
Why?
|
| Veterans | 1 | 2009 | 904 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 7277 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 4848 | 0.010 |
Why?
|